title: Infectious diseases. Ebola drug trials lurch ahead.
authors: Kai
authors: K
authors: Kupferschmidt
authors: Jon
authors: J
authors: Cohen
mesh_terms: D000577:Amides / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000639:trends; D003596:Cytosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004196:Disease Outbreaks / Q000517:prevention & control; D029043:Ebolavirus; D019142:Hemorrhagic Fever, Ebola / Q000188:drug therapy* / Q000401:mortality*; D006801:Humans; D063065:Organophosphonates / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use
chemical_list: D000577:Amides; D000911:Antibodies, Monoclonal; D000998:Antiviral Agents; D063065:Organophosphonates; D011719:Pyrazines; C000594176:ZMapp; C525733:brincidofovir; D003596:Cytosine; C462182:favipiravir